Oncolytic viruses mediating anti-tumor immunity in human cancer patients

Researchers developing new cancer therapeutics based on the next generation oncolytic viruses have published initial results that demonstrate an anti-tumor immunity of oncolytic viruses -- published for the first time in humans -- and indicate the strong efficacy of the next generation viruses against solid tumor cancers.

Read the whole article on Science Daily

More from Science Daily